We are a charity helping Aucklanders with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), Fibromyalgia, and Long COVID.
Phone: 0800 632 553
Dr Karl Morten
Speaking in Auckland, 12 December 2018
ME Auckland is proud to host International expert, Dr Karl Morten from Oxford University! All are welcome to this free talk.
Due to overwhelming demand, RSVPs are essential. Email us to RSVP (click here).
The talk will cover an update on Dr Morten's ME/CFS research followed by questions and answers from the audience (around 45 minutes for each).
Please see below for more information, or contact ME Auckland if you have any questions.
Topic
Over the last two years our research has started to unravel the complexity of ME/CFS by exploring the biology behind this complicated illness.
Factors have been identified in blood samples which can be used to differentiate patients from healthy controls with patients separating into three sub-groups. Active factors are present in the blood of patients capable of altering the energy production properties of normal cells. Clear differences are emerging whose role will be examined in more detail in future studies as we look towards treatment strategies and understanding the causes of this devastating condition.
During my talk I will outline our recent findings and discuss our future plans to tease out the most important factors behind ME/CFS.
- Dr Karl Morten
Time & place
Time
12 December 2018 (Wednesday)
6:30pm-8:30pm
Venue
Mt Albert Seior Citizens Hall
3 Wairere Ave
Mt Albert
Auckland
Next to the Rocket park. See map for parking:


Dr Karl Morten
I am Dr Karl Morten, Nuffield Department of Women's and Reproductive Health at the University of Oxford. My research career over the last 27 years has focused on the role of mitochondria in health and disease. Active current research interests include ME/CFS and re-purposing drugs which target mitochondria as anti-cancer therapeutics. I am a basic scientist by training with a series of multi-disciplinary collaborations around the world.
Recent research (linked below):